RecruitingPhase 2ACTRN12607000604404

A study looking at the effect positron emission tomography (PET) scans have on the treatment decisions specialists make in patients with suspected cancer of the pancreas.

A prospective study investigating the impact of the addition of FDG-PET/CT on treatment decisions compared to standard pre-operative work up for patients with suspected pancreatic, peri-ampullary or bile duct malignancies

Sponsor

Royal Brisbane Hospital

Enrollment

90 participants

Start Date

Jan 15, 2008

Study Type

Interventional

Conditions

Pancreatic and peri-ampullary cancers.

Summary

In addition to the standard pre-operative investigations you will also undergo a PET scan. Your results will be compared to people who only receive the routine pre-operative investigations, to see if the use of the PET scan changes the treatment plan. A PET scan is a non-invasive nuclear imaging test. In other cancers, particularly lung cancer, this scan can detect the spread of cancer better than other tests. If you have a suspected pancreatic cancer, the usual tests might include a CT (computed tomography) scan, ultrasound, MRI (magnetic resonance imaging) scan and an ERCP (endoscopic retrograde cholangiopancreatography). If a PET scan helps show the extent of the cancer better, your diagnosis will be more accurate and this might spare you unnecessary major surgery.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is testing whether a special type of scan called a PET (Positron Emission Tomography) scan can improve treatment decisions for people with suspected pancreatic cancer. Currently, patients have CT scans, ultrasounds, and MRI scans before surgery. A PET scan may show whether cancer has spread more accurately, which could help doctors plan surgery better and avoid unnecessary operations. Participants in this study will have a PET scan in addition to their standard pre-surgery tests. You may be eligible if: - You are 18 years of age or older - You have suspected or confirmed cancer of the pancreas, the bile duct, or the area where the bile duct meets the bowel (ampullary cancer) - Doctors believe surgery or radiotherapy with the aim of cure is possible for you - You are available for at least 12 months of follow-up from your scan date You may NOT be eligible if: - You have claustrophobia (unable to lie in a scanner) - You have uncontrolled diabetes - You are pregnant - You are unable to give informed consent - You have any condition that makes a PET/CT scan unsafe or impractical Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Adding 18 fluorodeoxyglucose positron emission tomography (FDG-PET) which,in other cancers, is better able to pick up cancer spread than other tests are. This scan will be done once at the time of dia

Locations(1)

QLD, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000604404